Researchers have been excited about Retatrutide , a novel dual compound showing significant data in early trials for body reduction . It functions by targeting both pathways : GLP-1 and GIP, which , when activated , assist influence appetite and enhance calorie burn. Initial observations suggest substantial size reduction and likely improvements fo